國立虎尾科技大學 |

Comparative Effectiveness in Surgical Oncology = Key Questions and How to Answer Them /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Comparative Effectiveness in Surgical Oncology/ edited by Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi.
其他題名:	Key Questions and How to Answer Them /
其他作者:	Bilimoria, Karl Y.
面頁冊數:	XV, 259 p. 14 illus., 6 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-12553-4
ISBN:	9783319125534

Comparative Effectiveness in Surgical Oncology = Key Questions and How to Answer Them /
Comparative Effectiveness in Surgical OncologyKey Questions and How to Answer Them /[electronic resource] :edited by Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi. - 1st ed. 2015. - XV, 259 p. 14 illus., 6 illus. in color.online resource. - Cancer Treatment and Research,1640927-3042 ;. - Cancer Treatment and Research,165.

Approaches to Answering Critical CER Questions -- Leveraging Comparative Effectiveness Research to Improve the Quality of Multidisciplinary Care for Breast Cancer Patients -- Comparative Effectiveness in Melanoma -- Comparative Effectiveness Research for Sarcoma -- Comparative Effectiveness in Thyroid Cancer -- Comparative Effectiveness in Head and Neck Malignancies -- Comparative Effectiveness Issues in Lung Cancer -- Comparative Effectiveness in Esophagogastric Cancer -- Comparative Effectiveness in Colon and Rectal Cancer -- Research Gaps in Pancreatic Cancer Research and Comparative Effectiveness Research Methodologies -- Comparative Effectiveness in Surgical Oncology: Hepatic Malignancies -- Comparative Effectiveness Research in Urologic Cancers -- Comparative Effectiveness Research in Gynecologic Oncology.

Despite tremendous recent advances in the treatment of most malignancies, there remain several critical questions for each cancer. This particularly true for the surgical management of solid-organ malignancies. Comparative effectiveness is a relatively new term which encompasses the age-old concepts of how best to treat cancer patients. Comparative effectiveness is defined as the direct comparison of healthcare interventions to determine which work best for which patients when considering the benefits and risks. The Institute of Medicine has defined comparative effectiveness research (CER) as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. CER is certainly best done with well-conducted randomized controlled trials. Unfortunately, clinical trials are not always feasible owing to the impracticality of conducting the trial, the considerable cost, and the time required to complete the trial. These challenges are even more pronounced with respect to surgical treatment. Thus alternative approaches may need to be considered in order to address pressing questions in the care of the oncology patient. These approaches may include well-conducted retrospective cohort studies from cancer registries and other data sources, decision and cost-effectiveness analyses, and other novel methodologies. This book lays out the current critical questions for each major malignancy and proposes approaches to gain answers to these pressing questions.

ISBN: 9783319125534

Standard No.: 10.1007/978-3-319-12553-4doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Comparative Effectiveness in Surgical Oncology = Key Questions and How to Answer Them /
LDR:03898nam a22004095i 4500 001 967638
003 DE-He213
005 20200706040335.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319125534 $9 978-3-319-12553-4
024 7 $a 10.1007/978-3-319-12553-4 $2 doi
035 $a 978-3-319-12553-4
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Comparative Effectiveness in Surgical Oncology $h [electronic resource] : $b Key Questions and How to Answer Them / $c edited by Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XV, 259 p. 14 illus., 6 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Treatment and Research, $x 0927-3042 ; $v 164
505 0 $a Approaches to Answering Critical CER Questions -- Leveraging Comparative Effectiveness Research to Improve the Quality of Multidisciplinary Care for Breast Cancer Patients -- Comparative Effectiveness in Melanoma -- Comparative Effectiveness Research for Sarcoma -- Comparative Effectiveness in Thyroid Cancer -- Comparative Effectiveness in Head and Neck Malignancies -- Comparative Effectiveness Issues in Lung Cancer -- Comparative Effectiveness in Esophagogastric Cancer -- Comparative Effectiveness in Colon and Rectal Cancer -- Research Gaps in Pancreatic Cancer Research and Comparative Effectiveness Research Methodologies -- Comparative Effectiveness in Surgical Oncology: Hepatic Malignancies -- Comparative Effectiveness Research in Urologic Cancers -- Comparative Effectiveness Research in Gynecologic Oncology.
520 $a Despite tremendous recent advances in the treatment of most malignancies, there remain several critical questions for each cancer. This particularly true for the surgical management of solid-organ malignancies. Comparative effectiveness is a relatively new term which encompasses the age-old concepts of how best to treat cancer patients. Comparative effectiveness is defined as the direct comparison of healthcare interventions to determine which work best for which patients when considering the benefits and risks. The Institute of Medicine has defined comparative effectiveness research (CER) as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. CER is certainly best done with well-conducted randomized controlled trials. Unfortunately, clinical trials are not always feasible owing to the impracticality of conducting the trial, the considerable cost, and the time required to complete the trial. These challenges are even more pronounced with respect to surgical treatment. Thus alternative approaches may need to be considered in order to address pressing questions in the care of the oncology patient. These approaches may include well-conducted retrospective cohort studies from cancer registries and other data sources, decision and cost-effectiveness analyses, and other novel methodologies. This book lays out the current critical questions for each major malignancy and proposes approaches to gain answers to these pressing questions.
650 0 $a Oncology . $3 1253469
650 0 $a Surgery. $3 644132
650 1 4 $a Oncology. $3 593951
700 1 $a Bilimoria, Karl Y. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066752
700 1 $a Minami, Christina A. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066753
700 1 $a Mahvi, David M. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066754
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319125541
776 0 8 $i Printed edition: $z 9783319125527
776 0 8 $i Printed edition: $z 9783319378688
830 0 $a Cancer Treatment and Research, $x 0927-3042 ; $v 165 $3 1254896
856 4 0 $u https://doi.org/10.1007/978-3-319-12553-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)